


Meissa Vaccines
Biotechnology Research • Redwood City, California, United States • 1-10 Employees
Company overview
| Headquarters | 1100 Island Dr, Suite 202, Downtown Redwood City, California 94065, US |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Synthetic Biology, Infectious Diseases, Vaccines, Parainfluenza, Respiratory Syncytial Virus, Rhinovirus, Human Metapneumovirus, Reverse Genetics |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
Key Contact at Meissa Vaccines
Roderick Tang
Senior Vice President
About Meissa Vaccines
Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children’s Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation – JLABS in South San Francisco.
Meissa Vaccines revenue & valuation
| Annual revenue | $3,500,000 |
| Revenue per employee | $1,167,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000 |
| Total funding | $30,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Meissa Vaccines Tech Stack
Discover the technologies and tools that power Meissa Vaccines's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Frequently asked questions
4.8
40,000 users



